Abeona Therapeutics (ABEO) Announces Enrollment of First Two Patients in Pivotal Expansion of Phase 1/2 Clinical Trial in MPS IIIA
Tweet Send to a Friend
Abeona Therapeutics Inc. (NASDAQ: ABEO) announced today that two patients were enrolled in the Company’s ABO-102 Phase 1/2 clinical trial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
